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Although many proteins require the binding of a li-
gand to be functional, the role of ligand binding during
folding is scarcely investigated. Here, we have reported
the influence of the flavin mononucleotide (FMN) cofac-
tor on the global stability and folding kinetics of Azoto-
bacter vinelandii holoflavodoxin. Earlier studies have
revealed that A. vinelandii apoflavodoxin kinetically
folds according to the four-state mechanism: I1 N un-
folded apoflavodoxin N I2 N native apoflavodoxin. I1 is
an off-pathway molten globule-like intermediate that
populates during denaturant-induced equilibrium un-
folding; I2 is a high energy on-pathway folding interme-
diate that never populates to a significant extent. Here,
we have presented extensive denaturant-induced equi-
librium unfolding data of holoflavodoxin, holofla-
vodoxin with excess FMN, and apoflavodoxin as well as
kinetic folding and unfolding data of holoflavodoxin. All
folding data are excellently described by a five-state mech-
anism: I1  FMNN unfolded apoflavodoxin  FMNN I2 
FMNN native apoflavodoxin FMNN holoflavodoxin. The
last step in flavodoxin folding is thus the binding of FMN to
native apoflavodoxin. I1, I2, and unfolded apoflavodoxin do
not interact to a significant extent with FMN. The autono-
mous formation of native apoflavodoxin is essential during
holoflavodoxin folding. Excess FMNdoes not accelerate ho-
loflavodoxin folding, and FMN does not act as a nucleation
site for folding. The stability of holoflavodoxin is so high
that evenunder strongly denaturing conditionsFMNneeds
to be released first before global unfolding of the protein
can occur.
Both in vivo and in vitro the folding of a protein is a
complex process. Current knowledge about this process
largely stems from in vitro studies of small proteins (20
kDa). The general picture that has emerged is that the topol-
ogy of the native state is a key factor in determining the rate
with which a protein folds (1). In addition, many proteins
form one or more metastable intermediates while folding.
Some of these intermediates are interpreted to be productive
species that accelerate the folding process, whereas others
appear to be misfolded conformations (2). The role an inter-
mediate has in kinetic folding also depends to some extent on
the experimental conditions used (3).
Many proteins require the binding of a non-covalently bound
ligand to be functional. The ligand, or cofactor, can vary from a
simple metal ion to a large organic molecule. The influences of
cofactor binding on the structure of the protein are manifold.
For example, apocytochrome c is largely unstructured; it only
folds upon incorporation of its heme cofactor (4). In contrast,
apoflavodoxin is structurally identical to holoflavodoxin, except
for increased dynamics in the region where the flavin cofactor
binds (5, 6). The quaternary structure of a protein also can
depend on the binding of a cofactor. For example, inactive
monomeric apolipoamide dehydrogenase forms active dimers
after incorporation of FAD (7).
Although many proteins require the binding of a non-co-
valently bound ligand to be functional, the role of ligand bind-
ing during folding is scarcely investigated. In principle, a li-
gand could bind to an unfolded protein and reduce the
conformational freedom of the polypeptide, thereby reducing
the conformational space sampled during protein folding. Such
ligands might potentially speed up the folding process by acting
as a nucleation site. In some cases, ligands indeed remain
bound to the unfolded protein (8, 9). However, in other cases,
ligands may not interact with non-native protein states and
only become incorporated in the protein during the final stages
of protein folding. In vivo, chaperones may also play a role in
the incorporation of a ligand. As kinetic folding studies of
proteins in the presence of their ligands are sparse, the kinetic
role of ligand binding during protein folding remains unclear.
Flavoproteins offer a good opportunity to study the role of
ligand binding during protein folding. The flavin cofactor is
generally non-covalently bound and can be reversibly removed
(10). Reconstitution of the holoprotein from its constituents can
be studied because of changes in spectroscopic properties that
accompany flavin binding.
Here, the influence of the flavin mononucleotide (FMN)1
cofactor on the folding of the 179-residue Azotobacter vinelandii
flavodoxin was investigated. Flavodoxins are monomeric pro-
teins (Fig. 1) that function as low potential one-electron carri-
ers in many microorganisms. Both the denaturant-induced
equilibrium unfolding and the kinetic folding of A. vinelandii
apoflavodoxin, i.e. flavodoxin in the absence of its cofactor, have
recently been studied in great detail (11–14). Apoflavodoxin is
structurally identical to holoflavodoxin except for increased
dynamics in the flavin binding region (5, 6). Apoflavodoxin
kinetic folding can be described by the model shown in Equa-
tion 1 (13)
I1 ^ U^ I2^ N (Eq. 1)
where U and N are unfolded and native apoflavodoxin, respec-
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tively, and I1 and I2 are folding intermediates. During dena-
turant-induced equilibrium unfolding apoflavodoxin populates
the relatively stable folding intermediate I1, which has molten
globule-like characteristics. During kinetic A. vinelandii
apoflavodoxin folding intermediate I1 acts as a trap. Interme-
diate I1 is off the direct folding route between unfolded and
native apoflavodoxin and has to unfold before native apofla-
vodoxin can be formed. Some folding apoflavodoxin molecules
manage to circumvent this trap and fold via a direct and rapid
route to the native state, on which the second folding interme-
diate I2 is located. This second intermediate is highly unstable
and never populates to a significant extent and is thus not
observed during denaturant-induced equilibrium unfolding of
apoflavodoxin. All folding apoflavodoxin molecules pass
through this high energy intermediate before reaching the
native state.
In this study we reported on (i) the kinetics of FMN binding
to native A. vinelandii apoflavodoxin, (ii) the kinetics of FMN
binding during A. vinelandii holoflavodoxin folding, (iii) the
release of FMN during A. vinelandii holoflavodoxin unfolding,
and (iv) the influence of FMN binding on the global stability of
A. vinelandii holoflavodoxin. By doing so, the role of FMN
during A. vinelandii flavodoxin folding was deciphered.
EXPERIMENTAL PROCEDURES
Materials—Guanidinium chloride (GuHCl, ultrapure) and potassium
pyrophosphate were from Sigma. In holoflavodoxin equilibrium unfold-
ing experiments, FMN purchased from Sigma was used without further
purification. In all other experiments FMN obtained during the prepa-
ration of apoflavodoxin (see below) and purified by reverse-phase HPLC
was used.
Protein Expression and Purification—Recombinant A. vinelandii
C69A holoflavodoxin was obtained and purified as described previously
(5, 11). The holoflavodoxin concentration was determined spectropho-
tometrically using an extinction coefficient of 11.3 mM1 cm1 at 452
nm (15). Apoflavodoxin was subsequently prepared by trichloroacetic
acid precipitation (11, 16) followed by gel filtration on a Superdex 200
prep grade column (Amersham Biosciences) to remove apoflavodoxin
molecules in an oligomeric state (13). The apoflavodoxin concentration
was determined spectrophotometrically using an extinction coefficient
at 280 nm of 29 mM1 cm1 (17).
Dissociation Constant of the Apoflavodoxin-FMN complex—The dis-
sociation constant of the apoflavodoxin-FMN complex was determined
using the quenching of FMN fluorescence upon binding to the apopro-
tein (18). A solution of 1.5 ml containing 210 nM FMN (based on the
extinction coefficient at 445 nm of 12.2 mM1 cm1 (19)) in 100 mM
potassium pyrophosphate, pH 6.0, was titrated with aliquots of 4.1 M
apoflavodoxin in the same buffer. After each addition of protein, the
system was allowed to equilibrate for 5 min in the dark. Subsequently,
the FMN fluorescence intensity was determined using a Cary eclipse
fluorimeter equipped with a peltier accessory operating at 25 °C (Var-
ian, Palo Alto, CA). Excitation was at 445 nm with a slit of 5 nm;
emission was recorded at 525 nm with a slit of 10 nm. The dissociation
constant of the apoflavodoxin-FMN complex was determined by fitting
the fluorescence emission to Equation 2, a slightly modified equation
compared with the one described in Ref. 19,
F  dFend FdCF

CAKD dCF CAKD dCF2 4CAdCF
2  (Eq. 2)
where F is the observed fluorescence intensity after each addition, d the
dilution factor (initial volume/total volume), Fend the remaining fluo-
rescence intensity after the titration (resulting from both fluorescence
of holoflavodoxin and traces of flavin impurities that are unable to bind
to apoflavodoxin), F the difference in molar emission intensity between
holoflavodoxin and free FMN, CF the initial concentration of FMN, CA
the total protein concentration (i.e. apo  holo), and KD the dissociation
constant of the apoflavodoxin-FMN complex. The fit resulted in values
for CA that indicate an apoflavodoxin stock solution of 4.4 M instead of
4.1 M. As a consequence, an extinction coefficient for A. vinelandii
apoflavodoxin at 280 nm of 27 mM1 cm1 was used in the rest of this
study instead of the value of 29 mM1 cm1 reported elsewhere (17).
FMN Binding Kinetics—Kinetic FMN binding experiments were per-
formed on a BioLogic (Claix, France) SFM-4 stopped-flow apparatus.
Solutions were thermostated at 25 °C using a circulating water bath.
FMN and apoflavodoxin, both in 100 mM potassium pyrophosphate, pH
6.0, were mixed in different ratios. Pseudo-first-order kinetics were
obtained by assuring at least a 10-fold excess of apoflavodoxin relative
to FMN. The final FMN concentration was 0.10 M in all cases, except
for the two highest protein concentrations (i.e. 10 and 12.5 M apofla-
vodoxin) where an FMN concentration of 1.0 M was used. Binding of
FMN to apoflavodoxin was monitored via the accompanying quenching
of the FMN fluorescence. The excitation wavelength was 446 nm using
an 8-nm slit, and emission was recorded above 475 nm using a cutoff
filter. Exponential equations were fitted to the kinetic traces using
ProFit (Quantumsoft, Zu¨rich, Switzerland).
Denaturant-induced Equilibrium Unfolding of Holoflavodoxin—
Three GuHCl-induced equilibrium unfolding experiments were done:
one with apoflavodoxin, one with holoflavodoxin, and one with holofla-
vodoxin in the presence of 100 M excess FMN. Unfolding was moni-
tored by circular dichroism (CD) and fluorescence spectroscopy. Before
measurements, all samples were equilibrated for at least 12 h at 25 °C
in the dark. The protein concentration was 4.0 M in all cases.
Steady-state far-UV CD measurements were performed on a Jasco
J715 spectropolarimeter (Tokyo, Japan) equipped with a PTC-348WI
peltier temperature control system. The cell chamber was purged with
dry nitrogen gas at a flow rate of 5 liters/min. Calibration was per-
formed with a solution of ammonium d10-camphorsulfonate in nano-
pure water, the concentration (0.06% w/v) of which was checked spec-
trophotometrically. GuHCl unfolding samples were measured in a
1-mm quartz cuvette (Starna, Hainault, England) at 222 and 255 nm,
and the corresponding signal was averaged over 3 min/wavelength at a
temperature of 25 °C. The ellipticity at 255 nm was subtracted from the
222 nm ellipticity as a baseline value. Before and after each measure-
ment series, 222 and 255 nm ellipticity values () of a buffer solution
(i.e. 100 mM potassium pyrophosphate, pH 6.0) were recorded. The
average net buffer ellipticity (i.e.222-255) was subtracted from all
sample ellipticities to allow quantitative comparison of ellipticity values
that result from different experiments.
Tryptophan fluorescence intensity was determined in a 1-ml quartz
cuvette (excitation path length 1 cm) using a Cary eclipse fluorimeter
equipped with a peltier accessory operating at 25 °C (Varian). Excita-
FIG. 1.Molscript schematic drawing (30) of the x-ray structure
of Azotobacter chroococcum flavodoxin (31), the sequence of
which is 95% identical to A. vinelandii flavodoxin. The secondary
structure depicted is based on the NMR spectroscopic data of A. vine-
landii holoflavodoxin (5). The FMN cofactor is shown in dark gray in
ball-and-stick representation.
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tion was at 280 nm with a slit of 5 nm; emission was measured for 5 s
at 350 nm with a slit of 2.5 nm. In the presence of 100 M excess FMN,
fluorescence emission was recorded using a 0.5-ml quartz cuvette that
was positioned with its long side (1-cm length) perpendicular to the
excitation beam, resulting in an excitation path length of 2 mm. Un-
folding of holoflavodoxin in the absence of excess FMNwas also followed
by recording the FMN fluorescence at 525 nm with a slit of 2.5 nm for
a period of 5 s.
A four-state model for equilibrium unfolding (holoflavodoxinN native
apoflavodoxinFMN N I1FMN N unfolded apoflavodoxinFMN; see
“Results and Discussion”) was fitted globally to the unfolding data of
apoflavodoxin, holoflavodoxin, and holoflavodoxin with 100 M excess
FMN using ProFit. Each GuHCl-induced equilibrium unfolding curve as
observed by fluorescence or CD spectroscopy is described by Equation 3
Yobs
j
j jDj (Eq. 3)
where j is the molar spectroscopic property of species j in a specific
unfolding curve in the absence of denaturant, j describes the depend-
ence of the molar spectroscopic property on the concentration denatur-
ant, [D]. The observed spectroscopic signal Y (i.e. fluorescence or CD
intensity) is the summation of contributions of all components, j (i.e.
holoflavodoxin, native apoflavodoxin, I1, and unfolded flavodoxin). The
fractional population [j] of species j in a specific unfolding experiment
and at a specific denaturant concentration is determined by the global
fit of the four-state model described above. The spectroscopic properties
of a particular protein species in different experiments are identical.
However, the spectroscopic properties detected of a particular species
differ slightly between different experiments. This effect is due to the
concentration of free FMN that differs between the experiments. For
example, FMN absorbs light, and as a result the fluorescence emission
of unfolded apoflavodoxin in the presence of FMN in an unfolding
experiment is slightly less compared with that of an unfolding experi-
ment in which no FMN is present. As a consequence, the spectroscopic
parameters were treated as local parameters in the fitting routine (see
below for exceptions). To properly weigh each data point in the global
fitting procedure, all unfolding curves were recorded with the same
number of data points and each data point was weighted according to
the corresponding standard error.
Native apoflavodoxin hardly populates in holoflavodoxin unfolding
experiments. Consequently, in these holoflavodoxin unfolding experi-
ments the spectroscopic properties of native apoflavodoxin (i.e. the -
and -values in Equation 3) could not be determined. However, the
latter spectroscopic parameters could be accurately determined in the
apoflavodoxin unfolding experiment. We assumed that these parame-
ters do not depend on the presence of holoflavodoxin or of free FMN. In
the global fit of all unfolding data the -values, as well as the -values,
of native apoflavodoxin were set to be equal. Their fitted values were
mainly determined by the apoflavodoxin unfolding experiment.
The denaturant concentration dependence of the spectroscopic prop-
erties of a specific species (i.e. the -values in Equation 3) can be
determined accurately only when the species populates for 100% over a
significant range of denaturant concentrations. However, the equilib-
rium folding intermediate I1 does not populate for 100%, and thus the
denaturant dependence of its CD and fluorescence intensity (i.e. -val-
ues) cannot be determined. Therefore, the -values of I1 are fixed to 0
(13).
Denaturant Dependence of Holoflavodoxin Folding Kinetics—Folding
kinetics of holoflavodoxin were measured by monitoring the FMN bind-
ing to folding apoflavodoxin molecules at 25 °C. Unfolded apoflavodoxin
in 3.0 M GuHCl and a solution of FMN, both in 100 mM potassium
pyrophosphate, pH 6.0, were mixed in a BioLogic SFM-4 stopped-flow
machine to a final FMN concentration of 10 M, a final protein concen-
tration of 1.0 M, and GuHCl concentrations ranging between 0.3 and
1.2 M. To determine the fluorescence intensity of unbound FMN in this
denaturant range, blank experiments were performed without apofla-
vodoxin. Binding of FMN to apoflavodoxin was monitored via the ac-
companying quenching of FMN fluorescence. The excitation wavelength
was 446 nm using an 8-nm slit and recording emission above 475 nm
using a cutoff filter. Kinetic traces were fitted to exponential equations
using ProFit.
The influence of Xaa-Pro peptide bond isomerization on the observed
holoflavodoxin folding kinetics was examined by repeating the experi-
ment described above with freshly unfolded apoflavodoxin, which has
all Xaa-Pro peptide bonds in the native trans conformation. This was
achieved by using a double-jump stopped-flow experiment in which
native apoflavodoxin was first unfolded for a period of 600 ms in 3.0 M
GuHCl. The resulting freshly unfolded apoflavodoxin solution was sub-
sequently immediately mixed with 100 mM potassium pyrophosphate,
pH 6.0, containing FMN to final concentrations of 10 M FMN, 1.0 M
apoflavodoxin, and 0.5 M GuHCl.
Denaturant Dependence of Holoflavodoxin Unfolding Kinetics—The
denaturant dependence of the unfolding kinetics of holoflavodoxin was
measured by mixing holoflavodoxin and GuHCl solutions, both in 100
mM potassium pyrophosphate, pH 6.0, in a BioLogic SFM-4 stopped-
flow machine to a final protein concentration of 1.0 M and final GuHCl
concentrations that range between 3.5 and 5.7 M. Unfolding of holofla-
vodoxin was monitored by the release of FMN, which results in a strong
increase of the FMN fluorescence intensity. The samples were excited
at 446 nm using an 8-nm slit, and emission was recorded above 475 nm
using a cutoff filter.
RESULTS AND DISCUSSION
Dissociation Constant of the A. vinelandii Apoflavodoxin-
FMN Complex—The FMN dissociation constant of A. vinelan-
dii holoflavodoxin in 100 mM potassium pyrophosphate at pH
6.0 is determined by a procedure in which aliquots of apofla-
vodoxin are titrated to an FMN solution (see “Experimental
Procedures”). In this procedure, use is made of the quenching of
FMN fluorescence upon its binding to apoflavodoxin (19, 20).
The corresponding binding curve is shown in Fig. 2, and the
fitted dissociation constant turns out to be (3.4 	 0.6) 1010 M.
This value is identical within error to the reported value of
(4.4 	 0.9) 1010 M for A. vinelandii apoflavodoxin in 50 mM
sodium phosphate at pH 7.0 (21).
Model Used to Describe Denaturant-induced A. vinelandii
Holoflavodoxin Unfolding—The GuHCl-induced equilibrium
unfolding of A. vinelandii apoflavodoxin is a three-state process
and involves the population of an intermediate as shown in
Equation 4
Apo ^ I1 ^ U (Eq. 4)
with Apo being native apoflavodoxin, I1 the folding intermedi-
ate with molten globule-like characteristics (11, 13), and U the
unfolded protein. The kinetic apoflavodoxin folding intermedi-
ate I2 (Equation 1) is not incorporated in Equation 4 as it is
shown not to populate to a detectable level during denaturant-
induced equilibrium unfolding of apoflavodoxin (13). Conse-
quently, if FMN would only bind to native apoflavodoxin, ho-
loflavodoxin denaturant-induced equilibrium unfolding would
be expected to be a four-state process as shown in Equation 5
FIG. 2. Determination of the dissociation constant of the A.
vinelandii apoflavodoxin-FMN complex using the quenching of
FMN fluorescence upon its binding to apoflavodoxin. A 210-nM
FMN solution was titrated with aliquots of a 4.1-M apoflavodoxin
solution. Equation 2 is fitted to the resulting fluorescence intensity data
as described under “Experimental Procedures.” The dissociation con-
stant is determined to be (3.4 	 0.6) 1010 M in 100 mM potassium
pyrophosphate, pH 6.0, at 25 °C.
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Holo ^ Apo  FMN ^ I1 FMN^ U FMN (Eq. 5)
with Holo being holoflavodoxin.
Equation 5 involves three equilibrium constants as shown in
Equation 6
K1 Holo/ApoFMN K2 Apo/I1 K3 I1/U
(Eq. 6)
in which K1 is the inverse of the dissociation constant KD of the
apoflavodoxin-FMN complex determined above. The denatur-
ant concentration dependence of these equilibrium constants is
given by Equation 7
KiD  Ki0expmiD/RT (Eq. 7)
in which [D] represents the denaturant concentration, Ki(0) is
the equilibrium constant (i.e. K1, K2, or K3 of Equation 6) in the
absence of denaturant, mi is a constant of proportionality that
describes the denaturant dependence of the equilibrium con-
stant Ki, R is the gas constant, and T is the absolute temper-
ature. Each equilibrium constant in Equation 6 is related to a
free energy difference 
G as shown in Equation 8.

Gi  RTlnKi RTlnKi0miD (Eq. 8)
The concentration of free FMN in solution affects the ratio
between apo- and holoflavodoxin concentrations according to
Equation 6. Consequently, the apparent stability of holofla-
vodoxin against unfolding, 
Gunf
app, depends on the concentra-
tion of free FMN, as is expressed in Equation 9 (22)

Gunf
app 
Gapo RTln1 FMNKD  (Eq. 9)
in which 
Gapo is the global stability of native apoflavodoxin.
Upon denaturant-induced unfolding of a fraction of the holofla-
vodoxin molecules, FMN is released and this affects the appar-
ent stability of the remaining holoflavodoxin molecules accord-
ing to Equation 9. Ignoring the latter phenomenon in the
analysis of equilibrium unfolding data of a ligand-binding pro-
tein will result in wrong stability values.
Denaturant-induced Unfolding Shows That A. vinelandii
Holoflavodoxin Unfolds according to a Four-state Process—
Because holoflavodoxin equilibrium unfolding is expected to be
a four-state process (Equation 5), it is not likely that the sta-
bilities and corresponding m-values of all the species involved
can be extracted from a single equilibrium unfolding experi-
ment. To determine these parameters, unfolding curves of
apoflavodoxin, holoflavodoxin, and holoflavodoxin with 100 M
FMN (i.e. a 25-fold excess of FMN relative to holoflavodoxin)
were determined. This excess of FMN ensures a virtually con-
stant FMN concentration during denaturant-induced holofla-
vodoxin unfolding and contributes 7.43 kcal/mol to the holofla-
vodoxin stability in the absence of denaturant (Equation 9).
The GuHCl-induced equilibrium unfolding data were ob-
tained by using tryptophan fluorescence (Fig. 3, A and B), FMN
fluorescence (Fig. 3C), and CD spectroscopy (Fig. 3D). All un-
folding curves were analyzed globally employing the four-state
unfolding model discussed (Equation 5; also see “Experimental
Procedures”). The dissociation constant (K1)
1 (Equation 6) is
fixed at zero molar denaturant to 3.4 1010 M as determined
above. In the case of holoflavodoxin unfolding without excess
FMN, the free FMN concentration is set to equal the total
protein concentration (i.e. 4 M) minus the actual concentration
of holoflavodoxin. In case of holoflavodoxin unfolding with ex-
cess FMN, the free FMN concentration is fixed to 100 M. In
our analysis both unfolded flavodoxin and the flavodoxin fold-
ing intermediate I1 did not interact to a significant extent with
FMN as is experimentally supported below. Thus, the stabili-
ties of native apoflavodoxin and of its folding intermediate I1,
both relative to unfolded apoflavodoxin, do not change between
the three flavodoxin equilibrium unfolding experiments.
Identical fluorimeter settings are used to record the unfold-
ing curves of apoflavodoxin and of holoflavodoxin without ex-
cess FMN. These settings need to be altered in case of holofla-
vodoxin unfolding with excess FMN because of the high optical
density of FMN at 280 nm. Therefore, the fluorescence inten-
sity values of holoflavodoxin with excess FMN cannot be di-
rectly compared with those of apoflavodoxin and holoflavodoxin
in Fig. 3A.
All four flavodoxin unfolding curves determined by fluores-
cence spectroscopy are well described by the four-state unfold-
ing model (Equation 5) as the global fit results show (Fig. 3,
A–C). Native holoflavodoxin without excess FMN is less fluo-
rescent than native apoflavodoxin (Fig. 3A) as the tryptophan
fluorescence in holoflavodoxin is quenched due to the bound
FMN molecule. Upon unfolding of apo- and holoflavodoxin,
virtually identical fluorescence intensity values at 350 nmwere
obtained (Fig. 3, A and B). The small differences observed were
most likely caused by the absorption of free FMN at 280 nm.
This showed that FMN does thus not interact to a significant
extent with unfolded flavodoxin.
The excellent fit of the four-state unfolding model to the
350-nm as well as the 525-nm fluorescence data showed that,
indeed, FMN does not significantly interact with I1 or with
unfolded flavodoxin. In the case of holoflavodoxin without ex-
cess FMN a hump is observed at 2.6 M GuHCl in its unfolding
curve measured by tryptophan fluorescence (Fig. 3B). This
hump is caused by the population of I1 and its fluorescence
properties. FMN does not interact to a significant extent with
I1 as supported by the monitoring of holoflavodoxin unfolding
without excess FMN via the fluorescence intensity of FMN at
525 nm (Fig. 3C). At this wavelength FMN gives a high fluo-
rescence intensity when free in solution, whereas the fluores-
cence of FMN bound to holoflavodoxin is quenched. Note that
the hump in the 350-nm tryptophan fluorescence data (Fig. 3B)
is not observed in the 525-nm flavin fluorescence data, which
shows that I1, just as U, does not interact with FMN.
All three flavodoxin unfolding curves determined by CD at
222 nm (Fig. 3D) are also well described by the four-state
unfolding model (Equation 5). Native holoflavodoxin without
excess FMN gives a stronger CD signal at 222 nm than native
apoflavodoxin (Fig. 3D). This is attributed to the formation of
some secondary structure in the FMN binding site of flavodoxin
upon binding of FMN (5, 6). Unfolded apo- and holoflavodoxin
have virtually identical ellipticity values (Fig. 3D). This sup-
ports that the presence of FMN does not affect the conforma-
tion of unfolded flavodoxin. In the case of holoflavodoxin with
100 M excess FMN, the ellipticity at 222 nm is 1 millidegree
less negative compared with the ellipticity of holoflavodoxin
without excess FMN (Fig. 3D). This difference is attributed to
the ellipticity of 100 M free FMN, which gives a positive CD
signal at 222 nm of 1 millidegree (data not shown).
The results of the global fit of Equation 5 to the flavodoxin
unfolding data are summarized in Table I. The equilibrium
populations of holoflavodoxin, native apoflavodoxin, I1, and of
unfolded flavodoxin, with and without 100 M excess FMN, are
shown in Fig. 4 as a function of denaturant concentration. In
summary, the denaturant-induced unfolding experiments
show that equilibrium unfolding of A. vinelandii holoflavodoxin
is well described by the four-state unfolding model holofla-
vodoxinN native apoflavodoxinFMNN I1FMNN unfolded
apoflavodoxinFMN.
Global Stability of Holoflavodoxin—The stabilities of native
apoflavodoxin and of the folding intermediate I1 and corre-
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sponding denaturant concentration dependences (i.e. m-values)
presented in Table I are within error identical to values re-
ported previously for denaturant-induced apoflavodoxin (un)-
folding (13). However, the seven unfolding curves presented
here result in much lower fitting errors. The recording of un-
folding curves of flavodoxin at different FMN concentrations
(i.e. no FMN present, with equimolar amounts of FMN, and
with excess FMN) together with the determination of the ho-
loflavodoxin dissociation constant is a powerful approach to
determine the stability of apo- and holoflavodoxin with high
accuracy. A similar approach, in which the ligand concentra-
tion is varied, can be used to accurately determine the stability
of other ligand-binding proteins.
The stability of a cofactor-binding protein is expected to
equal the sum of the stability of the apoprotein and the free
energy that is gained upon binding of the cofactor (22). Wit-
tung-Stafshede and co-workers (23) propose that FMN binding
has no effect on the denaturant-induced equilibrium unfolding
of Desulfovibrio desulfuricans flavodoxin, whereas the pres-
ence of FMN speeds up the folding of this protein (24). The
resulting thermodynamic conflict is handled by Wittung-
Stafshede and co-workers by assuming that unfolded D. desul-
furicans flavodoxin binds to FMN with nanomolar affinity,
which is a rather remarkable assumption.
In contrast, the results presented here show that the pres-
ence of FMN has a clear effect on the denaturant-induced
equilibrium unfolding of A. vinelandii flavodoxin (Fig. 3, A and
D). Apo- and holoflavodoxin start to unfold at largely different
concentrations of denaturant, and no appreciable interaction
between FMN and unfolded apoflavodoxin molecules is ob-
served. In addition, kinetic holoflavodoxin folding experiments
showed that FMN does not accelerate A. vinelandii flavodoxin
folding (see “The Kinetics of A. vinelandii Holoflavodoxin Fold-
ing”). The equilibrium unfolding data of A. vinelandii fla-
vodoxin are described by a four-state folding model (Equation
5) in which only native apoflavodoxin interacts with FMN.
Consequently, we concluded that in accordance with thermo-
dynamic theory the global stability of A. vinelandii holofla-
vodoxin equals the sum of the global stability of apoflavodoxin
and the free energy associated with FMN binding to native
apoflavodoxin. The global stability of A. vinelandii holofla-
vodoxin in the presence of 100 M FMN is 10.16  7.43  17.59
kcal/mol (Table I, Equation 9).
The Kinetics of FMN Binding to A. vinelandii Apoflavodoxin
Involve Two Rate Constants—The kinetics of FMN binding to
apoflavodoxin were determined at different protein concentra-
tions. Pseudo-first-order kinetics were obtained by using at
least a 10-fold excess of apoflavodoxin relative to FMN. In Fig.
5A a fluorescence intensity trace of FMN mixed with native
apoflavodoxin is shown. A sum of two exponentials is required
to properly describe the data (Fig. 5, B and C). Two rate
constants for FMN binding to apoflavodoxin were observed at
all protein concentrations used, with both rate constants lin-
early depending on the protein concentration (Fig. 6A). In
addition, two distinct rate constants for FMN binding were also
observed at all GuHCl concentrations at which apoflavodoxin is
still native (i.e. up to 1.0 M GuHCl) (data not shown). The larger
binding rate constant is associated with a large amplitude
(93 	 2% of the total signal on average), whereas the slower
binding process contributes for 7 	 2% to the observed FMN
binding kinetics (Fig. 6B). The small amplitude associated with
the slower binding process causes the observed scatter in the
corresponding binding rate constants (Fig. 6A). Second-order
rate constants for FMN binding to excess A. vinelandii apofla-
vodoxin of 0.95 	 0.02 and 0.27 	 0.03 M1 s1, respectively,
were derived from the protein concentration dependence of
FIG. 3.GuHCl-induced equilibrium unfolding data ofA. vinelan-
dii flavodoxin. The solid lines are the results of a global fit of a four-state
unfolding model (holoflavodoxin N native apoflavodoxin  FMN N
I1FMN N unfolded apoflavodoxinFMN, Equation 5) to all data pre-
sented, as described in the main text. In this model, FMN is either bound
to the protein to form holoflavodoxin or it is free in solution. A, the
unfolding of apoflavodoxin (O), holoflavodoxin (●), and of holoflavodoxin
with 100 M excess FMN (Œ) as monitored by tryptophan fluorescence at
350 nm. The fluorescence intensity values of the samples of holoflavodoxin
with 100 M FMN cannot be directly compared with those of the apofla-
vodoxin and holoflavodoxin samples as the excess of FMN leads to a high
optical density of the corresponding samples at the excitation wavelength
used and thus requires modified spectrometer settings. B, zoom-in graph
of the apoflavodoxin (O) and holoflavodoxin (●) data presented in panel A
that shows the hump that resides at the high denaturant concentration
part of the transition zone of the unfolding curve of holoflavodoxin. This
hump is caused by the population of I1 and its fluorescence properties. C,
unfolding of holoflavodoxin without excess FMN as monitored by FMN
fluorescence at 525 nm. Note that the hump seen in panel B is not present
here as I1, just as U, does not interact with FMN.D, the monitoring by CD
at 222 nm of the unfolding of apoflavodoxin (O), holoflavodoxin (●), and of
holoflavodoxin with 100 M excess FMN (Œ). The unfolding experiments
are done at 25 °C in 100 mM potassium pyrophosphate, pH 6.0, and the
protein concentration is 4.0 M.
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both FMN binding rate constants (Fig. 6A). The errors on the
second-order rate constants were estimated using a Chi-
squared test (25).
What causes the observed bi-exponential FMN binding ki-
netics of A. vinelandii apoflavodoxin? In the case of Desulfo-
vibrio vulgaris apoflavodoxin monophasic FMN binding kinet-
ics are observed in the absence of inorganic phosphate in the
buffer, whereas in the presence of phosphate FMN binding is
biphasic (26). Based on these observations and additional stud-
ies (27) it was proposed that in the absence of free phosphate
the 5-phosphate of FMN binds first to apoflavodoxin followed
by binding of the isoalloxazine ring. Inorganic phosphate was
proposed to bind to the phosphate binding site of a fraction of
theD. vulgaris apoflavodoxin molecules, leading to a preformed
isoalloxazine binding site (26). The latter allows the isoallox-
azine ring of FMN to bind first to apoflavodoxin in these mol-
ecules. Consequently, biphasic FMN binding kinetics were ob-
served for D. vulgaris apoflavodoxin in the presence of
phosphate. The slower kinetic phase was assigned to the phos-
phate-first binding mode and the faster phase to the ring-first
binding mode (26).
The studies of Murray and Swenson (26) prompted us to
determine the amount of free inorganic phosphate in the buffer
we used (i.e. 100 mM potassium pyrophosphate). 31P NMR
spectroscopy showed that 2% of the 31P nuclei present in this
buffer is present as phosphate (data not shown). Thus 4 mM
inorganic phosphate is present in the FMN binding studies of
A. vinelandii apoflavodoxin. Most likely, the bi-exponential
FMN binding kinetics of A. vinelandii apoflavodoxin are caused
by the binding of inorganic phosphate to the phosphate binding
site of a fraction of the A. vinelandii apoflavodoxin molecules.
The slower kinetic phase observed would be due to the phos-
phate-first binding mode of FMN to A. vinelandii apoflavodoxin
molecules that contain no inorganic phosphate. A. vinelandii
apoflavodoxin molecules that have an inorganic phosphate ion
bound would cause the faster kinetic phase observed due to the
ring-first binding mode of FMN to these molecules, just as is
observed for D. vulgaris apoflavodoxin (26).
The Rate of FMN Release Determines the A. vinelandii Ho-
loflavodoxin Unfolding Rate—Holoflavodoxin unfolding is
measured via the corresponding release of FMN, which results
in a strong increase of its fluorescence intensity (Fig. 7A). At
each GuHCl concentration studied (i.e. 3.5–5.7 M GuHCl), only
one unfolding rate constant was observed (Fig. 7B). Clearly, the
natural logarithm of the holoflavodoxin unfolding rate constant
depends linearly on the GuHCl concentration. The linear ex-
trapolation of the holoflavodoxin unfolding rate constants pre-
sented in Fig. 7B to 0 molar GuHCl leads to a holoflavodoxin
unfolding rate constant in water of (8.9	 0.8) 105 s1, and the
corresponding m-value is 0.65 	 0.01 kcal/molM1. The errors
on the rate constant and m-value were estimated using a Chi-
squared test (25).
It was previously suggested based on hydrogen/deuterium
exchange results that FMN release is probably the rate-
limiting step in A. vinelandii holoflavodoxin unfolding (5, 28),
as is also observed for D. vulgaris holoflavodoxin unfolding
(29). If true, the A. vinelandii holoflavodoxin unfolding rate
constant should equal the rate constant for FMN release from
holoflavodoxin. The rate constant for FMN release can be
deduced using the rate constant for FMN binding to A. vine-
landii apoflavodoxin and the dissociation constant of the
apoflavodoxin-FMN complex, both of which have been exper-
imentally determined in this study. The slowest FMN bind-
ing rate constant observed (i.e. 0.27 	 0.03 M1 s1) most
likely results from binding of FMN to apoflavodoxin mole-
cules that contain no inorganic phosphate ion. The dissocia-
tion constant KD of the apoflavodoxin-FMN complex is deter-
mined to be (3.4 	 0.6) 1010 M. This dissociation constant
describes the relative amounts of holoflavodoxin and apofla-
vodoxin at equilibrium. The rate constant for release of FMN
from holoflavodoxin equals the rate constant for FMN bind-
ing to apoflavodoxin  the dissociation constant of the apofla-
vodoxin-FMN complex and is (9 	 2) 105 s1. This value
matches with the holoflavodoxin unfolding rate constant in
water of (8.9	 0.8) 105 s1. Thus, FMN release is indeed the
rate-limiting step in A. vinelandii holoflavodoxin global
unfolding.
The data shown in Fig. 7B represent the GuHCl concentra-
tion dependence of the rate constant for FMN release from
A. vinelandii holoflavodoxin. Extrapolation of these data shows
TABLE I
Thermodynamic parameters obtained from the GuHCl-induced equilibrium unfolding of A. vinelandii holoflavodoxin
A four-state model for equilibrium unfolding (holoflavodoxin N native apoflavodoxin  FMN N I1  FMN N unfolded apoflavodoxin  FMN,
Equations 3–7) is fitted to the unfolding data of apoflavodoxin, holoflavodoxin, and of holoflavodoxin with 100 M excess FMN (see “Results and
Discussion”). The free energy differences in the absence of denaturant (
G) and corresponding denaturant concentration dependencies (m) are
given for the equilibrium between unfolded flavodoxinU and the apoflavodoxin folding intermediate I1 (
GUI and mUI), for the equilibrium between
intermediate I1 and native apoflavodoxin (
GIA and mIA), for the equilibrium between unfolded and native apoflavodoxin (
GUA and mUA), and for
the equilibrium between native apo- and holoflavodoxin in the theoretical presence of 1 M FMN (
Gb and mb), respectively. The errors given are
standard fitting errors.

GUI (kcal/mol) 3.47 	 0.05 mUI (kcal/molM
1) 1.84 	 0.01

GIA (kcal/mol) 6.69 	 0.01 mIA (kcal/molM
1) 4.38 	 0.02

GUA (kcal/mol) 10.16 	 0.06 mUA (kcal/molM
1) 6.22 	 0.02

Gb (kcal/mol) 12.86
a mb (kcal/molM
1) 0.79 	 0.01
a RTln(KD), with KD  3.4 10
10 M, the value determined for the FMN dissociation constant of A. vinelandii holoflavodoxin based on the data
presented in Figure 2.
FIG. 4. Normalized equilibrium population of holoflavodoxin
(solid line), native apoflavodoxin (dotted line), folding interme-
diate I1 (dashed line), and unfolded apoflavodoxin (dash-dotted
line) during the equilibrium unfolding of holoflavodoxin with-
out excess FMN (A) and with 100 M excess FMN (B), respec-
tively. The populations are derived from the results of the four-state
global fit to the experimental flavodoxin unfolding data shown in Fig. 3
and summarized in Table I.
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that in the absence of denaturant A. vinelandii holoflavodoxin
unfolds approximately once every 3 h.
The Kinetics of A. vinelandii Holoflavodoxin Folding—The
folding kinetics of apoflavodoxin from A. vinelandii in the ab-
sence of FMN have been studied in great detail (13). Single-
jump and interrupted refolding experiments showed that the
refolding kinetics of A. vinelandii apoflavodoxin are complex
and involve four processes, with rate constants 	1 to 	4 in order
of decreasing value. All four processes yield native apofla-
vodoxin molecules. The fastest process with rate constant 	1
corresponds to the rapid formation of native apoflavodoxin
along the most direct folding route from unfolded to native
FIG. 5. Two rate constants describe FMN binding to native A. vinelandii apoflavodoxin. A, kinetics of FMN binding to native
apoflavodoxin as monitored by the quenching of the FMN fluorescence emission above 475 nm in a stopped-flow instrument. B, residuals of a fit
of a single exponential equation to the data. C, residuals of a fit of a sum of two exponential equations to the data with the fitted rate constants
being 2.86 	 0.02 and 0.98 	 0.08 s1, respectively. The final flavodoxin concentration is 3 M, and the final FMN concentration is 0.10 M, both
in 100 mM potassium pyrophosphate. pH 6.0, at 25 °C.
FIG. 6. Observed rate constants for FMN binding to A. vinelandii apoflavodoxin as a function of the final protein concentration
in 100 mM potassium pyrophosphate, pH 6.0, at 25 °C. The final FMN concentration is 0.10 M in all cases, except for the two highest protein
concentrations used (i.e. 10 and 12.5 M), where it is 1.0 M. A, the protein concentration dependence of both observed rate constants is fitted to
a straight line that crosses the origin; the corresponding slopes are the pseudo-first-order rate constants. The faster of the two observed FMN
binding rate constants (●) fits to a pseudo-first-order rate constant of 0.95 	 0.02 M1 s1, whereas the slower one (O) fits to a pseudo-first-order
rate constant of 0.27 	 0.03 M1 s1. B, relative amplitudes associated with the faster (●) and the slower (O) observed rate constants for FMN
binding to apoflavodoxin as a function of the protein concentration. The error bars give the standard fitting errors of the rate constants and of the
relative amplitudes, respectively.
FIG. 7. Unfolding kinetics of A. vinelandii holoflavodoxin monitored by FMN fluorescence emission. A, fluorescence emission
spectrum of free FMN (gray lines) and of the same concentration of FMN in the presence of an equimolar amount of A. vinelandii apoflavodoxin
(black lines), showing the effect of the absence (dashed lines) and the presence (solid lines) of 4 M GuHCl. In the absence of denaturant, FMN binds
to apoflavodoxin; as a result, its fluorescence intensity is strongly quenched. Apoflavodoxin is unfolded in 4 M GuHCl; as a result, the FMN
fluorescence emission spectrum in the presence of an equimolar amount of apoflavodoxin and 4 M GuHCl is indistinguishable from the one of free
FMN in 4 M GuHCl. Apoflavodoxin (when present) and FMN concentrations are 1 M in 100 mM potassium pyrophosphate, pH 6.0, at 25 °C.
Excitation is at 446 nm, and a 5-nm slit is used. B, natural logarithm of the single observed rate constant for A. vinelandii holoflavodoxin unfolding
(O) as a function of the GuHCl concentration. At the X sign two data points overlap. The solid line is the result of a linear fit to all data shown.
The unfolding rate constant extrapolated to water is (8.9	 0.8) 105 s1, and the correspondingm-value is 0.65	 0.01 kcal/molM1. The error bars
show the standard errors of the rate constants. The experiments are done at 25 °C, and final conditions are 1.0 M flavodoxin in 100 mM potassium
pyrophosphate, pH 6.0.
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protein. Only a small fraction (11%) (13) of the folding apofla-
vodoxin molecules follows the direct folding route. On this
route (unfolded apoflavodoxin N I2 N native apoflavodoxin), a
high energy intermediate I2 is transiently formed. The process
with rate constant 	2 corresponds to the formation of native
apoflavodoxin via a relatively stable intermediate I1 (I1 N
unfolded apoflavodoxinN I2N native apoflavodoxin, Equation
1). The unfolding of the latter intermediate is the rate-limiting
step in the formation of native apoflavodoxin with rate con-
stant 	2. The two slowest folding processes (with rate constants
	3 and 	4) are because of Xaa-Pro peptide bond isomerizations
in the unfolded state (13).
In this study the influence of FMN on the folding kinetics of
A. vinelandii flavodoxin was investigated. Unfolded apofla-
vodoxin in 3.0 M GuHCl was mixed into buffer containing FMN,
and the subsequent binding of FMN to the folding apofla-
vodoxin molecules was monitored, as shown in Fig. 8A. A sum
of three exponential equations was needed to properly fit the
time-dependent fluorescence signal obtained, which led to the
identification of three observable folding rate constants.
The slowest folding rate constant observed in the holofla-
vodoxin folding experiment is equal to 	3 observed during
apoflavodoxin kinetic folding, which originates from Xaa-Pro
peptide bond isomerizations (a rate constant of 0.3 s1, data
not shown). The slowest apoflavodoxin folding rate constant 	4
of 0.03 s1 in the absence of denaturant, which also originates
from Xaa-Pro peptide bond isomerizations, cannot be extracted
from the data. Rate constant 	4 was not sufficiently sampled in
the holoflavodoxin kinetic folding traces, as these traces were
recorded for a period of only 10 s. As both 	3 and 	4 originate
from Xaa-Pro peptide bond isomerizations, they do not inform
about the folding mechanism of both apo- and holoflavodoxin.
The dependence of the two fastest rate constants for both
apoflavodoxin folding and holoflavodoxin folding (i.e. 	1 and 	2)
on the GuHCl concentration is shown in Fig. 8B. Up to 0.7 M
GuHCl, the rate constants for holoflavodoxin folding as ob-
served via FMN binding are identical within error to those
observed for apoflavodoxin folding. Clearly, excess FMN does
not accelerate flavodoxin folding, and FMN thus does not act as
a nucleation site for flavodoxin folding. Instead, in the presence
of excess FMN, formation of native apoflavodoxin is the rate-
limiting process in the folding of A. vinelandii holoflavodoxin.
Above 0.7 M GuHCl, the FMN binding rate constants devi-
ated from the apoflavodoxin folding rate constants. At these
concentrations of denaturant both folding and unfolding pro-
cesses contributed to the observed kinetics, and as holofla-
vodoxin unfolds slower than apoflavodoxin, the resulting ob-
served rate constants for holoflavodoxin folding were lower
than those of apoflavodoxin folding.
The largest folding rate observed during apoflavodoxin fold-
ing (i.e. 	1) contains contributions from the formation of folding
intermediates with non-native Xaa-Pro peptide bond isomers
(13). In case these intermediates are able to bind FMN, this
could influence the observed holoflavodoxin folding kinetics as
monitored by FMN binding (Fig. 8B). However, freshly un-
folded apoflavodoxin gave upon folding in the presence of FMN
at 0.5 M GuHCl rate constants for FMN binding that were
identical within error to the rate constants for folding of equi-
librium unfolded apo- and holoflavodoxin (Fig. 8B). In freshly
unfolded apoflavodoxin (made by unfolding apoflavodoxin for
600 ms in 3.0 M GuHCl) the vast majority of the Xaa-Pro
peptide bond isomers was native. Hence, apoflavodoxin folding
intermediates with non-native Xaa-Pro peptide bonds did not
bind FMN.
In Fig. 8A the time-dependent fluorescence intensity of free
FMN in a kinetic folding experiment is shown, recorded under
identical circumstances as for holoflavodoxin folding, except
that now no protein was present. The initial fluorescence in-
tensity of FMN during kinetic holoflavodoxin folding was some-
what (2%) higher than observed in the blank experiment in
which flavodoxin was absent. This higher intensity might sug-
gest a weak association of FMN with the folding apoflavodoxin
molecules, which would result in FMN being less accessible to
GuHCl compared with unbound FMN. We observed that the
fluorescence intensity of free FMN was quenched by the pres-
ence of GuHCl (24% quenching at 0.5 M GuHCl, data not
shown).
No indications for the association of FMNwith apoflavodoxin
unfolded in 4 M GuHCl were observed. First, at this denaturant
concentration the fluorescence emission spectra of FMN in the
presence and in the absence of apoflavodoxin were identical
(Fig. 7A). Second, 1H NMR spectra of holoflavodoxin unfolded
in 4 M GuHCl showed sharp resonances of FMN protons at
frequencies that coincided within the spectral resolution of 0.01
FIG. 8. Folding kinetics of A. vinelandii holoflavodoxin. A, time-dependent fluorescence intensity resulting from FMN binding to folding
A. vinelandii apoflavodoxin molecules (black line) detected via the quenching of the FMN fluorescence above 475 nm. The trace is obtained by
mixing unfolded apoflavodoxin (in 3.0 M GuHCl) with buffer containing FMN to final conditions of 10 M FMN, 1.0 M flavodoxin, 0.50 M GuHCl,
100 mM potassium pyrophosphate, pH 6.0, at 25 °C. Under these final conditions apoflavodoxin is in its native state. The gray line shows the trace
obtained when repeating the same experiment in the absence of protein. The steady decrease in fluorescence emission observed in the latter trace
is caused by the time-dependent photobleaching of FMN. B, chevron plot of the two largest observed rate constants for A. vinelandii holoflavodoxin
folding as observed by changes in FMN fluorescence above 475 nm (●, 	1; f, 	2). For comparison, the corresponding A. vinelandii apoflavodoxin
folding rate constants as observed by changes in tryptophan fluorescence intensity are shown as well (open symbols). The two smallest folding rate
constants for both apo- and holoflavodoxin folding (i.e. 	3 and 	4) are not shown as they do not inform about the folding mechanism of flavodoxin,
because they originate from Xaa-Pro peptide bond isomerizations. Up to 0.7 M GuHCl, the folding rate constants observed for both holo- and
apoflavodoxin are identical within error. The 	1 and 	2 rate constants for refolding of freshly unfolded apoflavodoxin (made by unfolding
apoflavodoxin for a period of 600 ms in 3.0 M GuHCl) in the presence of FMN at 0.5 M GuHCl are shown in gray. The rate constants are plotted
on a logarithmic scale. Final conditions are 1.0 M flavodoxin in 100 mM potassium pyrophosphate, pH 6.0, at 25 °C. In the case of holoflavodoxin,
10 M FMN is present as well. Apoflavodoxin folding data are taken from Ref. 13.
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ppm with those of FMN in 4 M GuHCl in the absence of fla-
vodoxin (data not shown). Third, the observed flavodoxin fold-
ing kinetics were not affected by the presence of excess FMN
(Fig. 8B). Fourth, the holoflavodoxin denaturant-induced equi-
librium unfolding data (Fig. 3) were excellently described by
assuming that only native apoflavodoxin binds FMN. In sum-
mary, if any association of FMN with unfolded apoflavodoxin
molecules exists, it must be weak.
FMN did not associate with the apoflavodoxin folding inter-
mediate I1 as well. Up to 0.7 M GuHCl the observed flavodoxin
folding kinetics were not affected (Fig. 8B): 	2 increased with
increasing denaturant concentration for both apo- and holofla-
vodoxin. This increase reflects the unfolding of the off-pathway
apoflavodoxin folding intermediate I1 (13). As the presence of
FMN leads to no alteration in the latter phenomenon, binding
of FMN to I1 seems unlikely. As discussed, the latter is sup-
ported by the holoflavodoxin equilibrium unfolding data being
well described by assuming that only native apoflavodoxin
binds FMN to a significant extent. In accordance, at 2.6 M
GuHCl, where I1 is populated for 11.7% whereas native holofla-
vodoxin is populated for less than 1% (Fig. 4A), the entire
fluorescence emission spectra (ranging from 475 to 675 nm) of
FMN in the presence and in the absence of apoflavodoxin were
identical (data not shown). In summary, the off-pathway inter-
mediate I1 does not bind FMN with an appreciable binding
constant. In addition, the high energy on-pathway intermedi-
ate I2 (Equation 1) exists for such a short time (13) that FMN
binding to this intermediate must also be negligible.
Under the conditions investigated the formation of native
apoflavodoxin molecules was the rate-limiting step in A. vine-
landii holoflavodoxin folding. Therefore, FMN binding to na-
tive apoflavodoxin must be the final step in A. vinelandii ho-
loflavodoxin folding. Taking all observations together, the
kinetic model for A. vinelandii apoflavodoxin folding can now
be extended to describe kinetic holoflavodoxin folding: I1 
FMNN unfolded apoflavodoxin  FMNN I2  FMNN native
apoflavodoxin  FMN N holoflavodoxin.
CONCLUSION
The folding data of A. vinelandii holoflavodoxin have
shown that first apoflavodoxin folds to its native state. FMN
binding to native apoflavodoxin was the subsequent last step
in holoflavodoxin folding. Flavodoxin folding was an autono-
mous process that in vitro did not require the assistance of
chaperone molecules. Excess FMN did not accelerate holofla-
vodoxin kinetic folding, andFMNdid not act as a nucleation site for
flavodoxin folding. The kinetic folding of holoflavodoxin is described
by I1  FMNN unfolded apoflavodoxin  FMNN I2  FMNN
native apoflavodoxin  FMN N holoflavodoxin. No indications
exist for unfolded apoflavodoxin, the molten globule-like apofla-
vodoxin off-pathway folding intermediate I1, or the high energy
on-pathway intermediate I2 to interact to a significant extent with
FMN.The stability of holoflavodoxin fromA. vinelandiiwas so high
that even under strongly denaturing conditions FMN needed to be
released first before global unfolding of the protein could occur. This
global unfolding is a rare event, occurring approximately once ev-
ery 3 h in the absence of denaturant.
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